Amalgamated Bank Emergent Bio Solutions Inc. Transaction History

Amalgamated Bank

$12.1 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$1.5 - $3.41 $4,060 - $9,230	-2,707 Reduced 60.55%	1,764 $4,000
Q4 2023 Feb 06, 2024	SELL	$1.82 - $3.16 $955 - $1,659	-525 Reduced 10.51%	4,471 $11,000
Q3 2023 Nov 08, 2023	SELL	$3.17 - $7.91 $43,238 - $107,892	-13,640 Reduced 73.19%	4,996 $17,000
Q2 2023 Aug 11, 2023	SELL	$7.35 - $13.21 $4,167 - $7,490	-567 Reduced 2.95%	18,636 $136,000
Q1 2023 May 02, 2023	SELL	$7.79 - $16.29 $4,720 - $9,871	-606 Reduced 3.06%	19,203 $199,000
Q4 2022 Feb 10, 2023	SELL	$11.0 - $21.45 $11,979 - $23,359	-1,089 Reduced 5.21%	19,809 $234,000
Q3 2022 Nov 09, 2022	BUY	$20.09 - $35.8 $1,245 - $2,219	62 Added 0.3%	20,898 $439,000
Q2 2022 Aug 15, 2022	SELL	$27.42 - $43.63 $20,948 - $33,333	-764 Reduced 3.54%	20,836 $647,000
Q1 2022 Jun 30, 2022	SELL	$36.48 - $52.22 $40,055 - $57,337	-1,098 Reduced 4.84%	21,600 $887,000
Q4 2021 Feb 15, 2022	SELL	$33.11 - $55.01 $301,532 - $500,976	-9,107 Reduced 28.63%	22,698 $987,000
Q3 2021 Oct 29, 2021	SELL	$50.07 - $66.05 $111,105 - $146,564	-2,219 Reduced 6.52%	31,805 $1.59 Million
Q2 2021 Aug 16, 2021	BUY	$56.61 - $80.46 $1.54 Million - $2.19 Million	27,206 Added 399.03%	34,024 $2.14 Million
Q1 2021 May 13, 2021	SELL	$86.23 - $125.19 $54,066 - $78,494	-627 Reduced 8.42%	6,818 $633,000
Q4 2020 Feb 12, 2021	BUY	$79.17 - $111.47 $11,242 - $15,828	142 Added 1.94%	7,445 $667,000
Q3 2020 Oct 30, 2020	SELL	$81.91 - $134.94 $19,740 - $32,520	-241 Reduced 3.19%	7,303 $755,000
Q2 2020 Aug 10, 2020	SELL	$54.33 - $89.52 $49,168 - $81,015	-905 Reduced 10.71%	7,544 $597,000
Q1 2020 May 13, 2020	SELL	$49.34 - $68.76 $7,943 - $11,070	-161 Reduced 1.87%	8,449 $489,000
Q4 2019 Feb 13, 2020	BUY	$51.21 - $59.06 $6,554 - $7,559	128 Added 1.51%	8,610 $465,000
Q3 2019 Nov 13, 2019	SELL	$40.6 - $57.2 $5,887 - $8,294	-145 Reduced 1.68%	8,482 $443,000
Q2 2019 Aug 14, 2019	BUY	$39.92 - $53.86 $56,207 - $75,834	1,408 Added 19.5%	8,627 $417,000
Q1 2019 May 15, 2019	BUY	$48.23 - $66.16 $11,044 - $15,150	229 Added 3.28%	7,219 $365,000
Q4 2018 Feb 15, 2019	BUY	$55.63 - $73.24 $388,853 - $511,947	6,990 New	6,990 $414,000
Q3 2018 Nov 14, 2018	SELL	$52.05 - $66.51 $371,793 - $475,080	-7,143 Closed	0 $0
Q2 2018 Jul 18, 2018	BUY	$48.33 - $55.64 $112,850 - $129,919	2,335 Added 48.56%	7,143 $361,000
Q1 2018 May 22, 2018	SELL	$44.44 - $54.39 $3,688 - $4,514	-83 Reduced 1.7%	4,808 $253,000
Q4 2017 Feb 13, 2018	BUY	$37.77 - $47.75 $184,733 - $233,545	4,891	4,891 $227,000

Others Institutions Holding EBS

# of Institutions

160

Shares Held

33.8M

Call Options Held

453K

Put Options Held

931K

Black Rock Inc. New York, NY

3.84M
Shares

$33.7 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.4M
Shares

$29.9 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.49M
Shares

$21.9 Million
0.03% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

2.22M
Shares

$19.6 Million
0.0% of portfolio
State Street Corp Boston, MA

1.91M
Shares

$16.8 Million
0.0% of portfolio

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $438M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account